Rankings
▼
Calendar
ALDX Q4 2021 Earnings — Aldeyra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ALDX
Aldeyra Therapeutics, Inc.
$318M
Q4 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$61,271
Operating Income
-$15M
Net Income
-$16M
EPS (Diluted)
$-0.27
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$12M
Stock-Based Comp.
$984,473
Balance Sheet
Total Assets
$233M
Total Liabilities
$27M
Stockholders' Equity
$206M
Cash & Equivalents
$230M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$61,271
$0
—
Operating Income
-$15M
-$10M
-61.6%
Net Income
-$16M
-$11M
-39.5%
← FY 2021
All Quarters
Q1 2022 →